Evidence map›Paper›PMID 42635130›Full record

ArticleNucleic acids research2026

CpG content contributes to tissue-resident macrophage enhancer selection.

Dóra Bojcsuk, Zsófia Varga, Zsuzsanna Kolostyák, Petros Tzerpos, Noemí Caballero-Sánchez, Tímea Cseh, Andreas Patsalos, Zsolt Czimmerer, László Nagy, Gergely Nagy

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dóra BojcsukDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.ORCID 0000-0001-5091-7237
Zsófia VargaHUN-REN Biological Research Centre, Institute of Genetics, Macrophage Polarization Group, Szeged, Hungary.
Zsuzsanna KolostyákDepartment of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary.ORCID 0000-0003-3337-7210
Petros TzerposDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Noemí Caballero-SánchezDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Tímea CsehDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Andreas PatsalosDepartments of Medicine and Biomedical Engineering, Johns Hopkins University School of Medicine, Institute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Zsolt CzimmererHUN-REN Biological Research Centre, Institute of Genetics, Macrophage Polarization Group, Szeged, Hungary.ORCID 0000-0002-3407-5006
László NagyDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Gergely NagyDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.ORCID 0000-0002-3273-731X

Funding

DHA-derived resolvin production andsignaling in tissue repair macrophages in metabolic diseaseR01DK124782 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI NAGY, LASZLO, SPITE, MATTHEW R · 2020 to 2023
$2.3M
Nuclear receptor, PPARg in macrophage polarization, hyperinflammatory gene expression and lung injuryR01HL170426 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Laszlo Nagy · 2024 to 2026
$1.9M
PPARgamma as an architectural regulator of gene expression in endocrine signalingR01DK115924 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI NAGY, LASZLO · 2018 to 2021
$1.6M
European UnionHungarian Academy of Sciences KGYNK2026-43Hungarian Scientific Research FundMuscular Dystrophy Association 1064247National Research, Development and Innovation Office 2023-1.1.1-PIACI_FÓKUSZ-2024-00036National Research, Development and Innovation Office K145994NHLBI NIH HHS R01 HL170426NIDDK NIH HHS R01 DK115924NIDDK NIH HHS R01 DK124782NIH HHS DK115924NIH HHS DK124782NIH HHS HL170426Nuclear Hormone Receptor Laboratory ADVANCED-152422Nuclear Hormone Receptor Laboratory FK146945Nuclear Hormone Receptor Laboratory OTKA PD137902
6 · The paper itself

Abstract

Tissue-resident macrophages acquire specialized identities through transcription factor networks operating in distinct chromatin environments. Early growth response 2 (EGR2) contributes both to alveolar macrophage identity and to interleukin (IL)-4-driven polarization of bone marrow-derived macrophages, yet the regulatory principles enabling its function across these contexts remain unclear. By integrating RNA-seq and ATAC-seq data from wild-type and Egr2-deficient macrophages, we show that macrophage identity is constrained by DNA methylation-dependent cis-regulatory landscapes. Alveolar macrophage-specific enhancers are predominantly CpG rich and hypomethylated, a feature shared with additional tissue-resident macrophage populations, whereas bone marrow-derived macrophage-accessible regulatory regions are largely CpG poor. Although IL-4 induces EGR2 together with KLF4 and DEC1 in bone marrow-derived macrophages, this transcription factor module fails to engage CpG-rich enhancers, indicating that the bone marrow-derived macrophage regulatory network lacks additional alveolar macrophage-specific components required for their activation. These findings identify CpG content as a determinant of enhancer competence and provide a mechanistic explanation for the context-dependent activity of EGR2 in macrophages, placing macrophage plasticity under the control of sequence-encoded epigenetic constraints.

Indexed as

CpG IslandsEarly Growth Response Protein 2Enhancer Elements, GeneticMacrophagesMacrophages, AlveolarAnimalsDNA MethylationInterleukin-4Kruppel-Like Factor 4MiceMice, Inbred C57BLEarly Growth Response Protein 2Egr2 protein, mouseInterleukin-4Klf4 protein, mouseKruppel-Like Factor 4

Identifiers

PMID42635130
PMCPMC13501131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.